Chief Executive, Gilead Sciences
Appears in 1 story
Steering lenacapavir pricing and supply deals
Lenacapavir recorded zero infections across 4,493 person-years in extended follow-up data confirmed at AIDS 2026, which closed in Rio de Janeiro on July 31. The conference ended with the drug's scientific case stronger than ever and its delivery prospects getting worse.
Updated Jul 31
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
